| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.037 | 0.6 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |